Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal recovery from rocuronium-induced muscle relaxation in elderly patients under remimazolam vs propofol anesthesia
jRCT1031260098Recruiting
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam, propofol and rocuronium in None (2 arms), sponsored by none. Primary endpoint: Time to TOF ratio of 90%. Started Apr 2026; status: recruiting.
02
Drugs
remimazolampropofolrocuronium
Beyond the preview
Go deeper on jRCT1031260098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031260098.